CliffBio
small molecule

KLOR-CON

POTASSIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyUPSHER SMITH LABORATORIES LLC

Drug detail

Brand nameKLOR-CON
Active ingredientPOTASSIUM CHLORIDE
Strength8MEQ
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2015
Marketing statusDISCN

More from UPSHER SMITH LABORATORIES LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

KLOR-CON patent cliff — loss of exclusivity — | CliffBio